Not Yet Recruiting
Study of SHR-A1921 Combined Adebrelimab in HR-positive, HER2-negative Advanced Breast Cancer
NCT06470672
- Conditions
- Advanced Breast Cancer, Hormone-receptor-positive Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
- Locations
-
- Fudan Cancer Hospital Shanghai, Shanghai Municipality, China